CN Patent

CN119403557A — 用于治疗癌症的menin-mll抑制剂

Assigned to Syndax Pharmaceuticals Inc · Expires 2025-02-07 · 1y expired

What this patent protects

本公开涉及用menin‑MLL抑制剂在有此需要的受试者中治疗结肠直肠癌的方法，所述menin‑MLL抑制剂包括化合物A。本公开还提供了针对各种适应症施用化合物A的方法。

USPTO Abstract

本公开涉及用menin‑MLL抑制剂在有此需要的受试者中治疗结肠直肠癌的方法，所述menin‑MLL抑制剂包括化合物A。本公开还提供了针对各种适应症施用化合物A的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN119403557A
Jurisdiction
CN
Classification
—
Expires
2025-02-07
Drug substance claim
No
Drug product claim
No
Assignee
Syndax Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.